Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas

被引:15
作者
Feltmate, CM
Lee, KR
Johnson, M
Schorge, JO
Wong, KK
Hao, K
Welch, WR
Bell, DA
Berkowitz, RS
Mok, SC
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol,Div Gynecol Onc, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[5] Dana Farber Canc Inst, Gillette Ctr Womens Canc, Boston, MA 02115 USA
[6] Univ Texas, SW Med Sch, Dept Obstet & Gynecol, Div Gynecol Oncol, Dallas, TX USA
[7] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
关键词
D O I
10.1158/1078-0432.CCR-05-1008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Mucinous adenocarcinoma of the ovary is one of the common histologic types of ovarian cancer. Its pathogenesis is largely unknown. In addition, the differential diagnosis of metastatic mucinous Carcinomas to the ovaries, particularly those originating from the appendix, remains challenging. The purpose of this study is to identify molecular biomarkers for mucinous ovarian adenocarcinoma and compare them with those of appendiceal origin. Experimental Design: Genome-wide loss-of-heterozygosity (LOH) analysis was done on DNA isolated from 28 microdissected primary mucinous ovarian carcinomas and five appendiceal adenocarcinomas. Markers from high-loss regions were selected for further analysis on a total of 32 ovarian and 14 appendiceal cancers. Results: High levels of LOH rates (> 40%) were detected on chromosome arms 9p, 17p, and 21q in mucinous ovarian carcinoma cases. The frequency of allelic loss was similar between high-grade and low-grade mucinous ovarian carcinoma cases but was significantly higher in ovarian versus appendiceal cases. In addition, LOH rates on five chromosomal loci were statistically different between ovarian and appendiceal carcinomas. Conclusion: A high frequency of LOH can be found in mucinous ovarian adenocarcinomas independent of grade. Despite histologic similarities between mucinous ovarian carcinomas and metastatic appendiceal carcinomas, they have distinct LOH profiles, which may be used for distinguishing the two diseases.
引用
收藏
页码:7651 / 7657
页数:7
相关论文
共 36 条
[1]   Genetic analysis of synchronous mucinous tumors of the ovary and appendix [J].
Chuaqui, RF ;
Zhuang, ZP ;
Emmertbuck, MR ;
Bryant, BR ;
Nogales, F ;
Tavassoli, FA ;
Merino, MJ .
HUMAN PATHOLOGY, 1996, 27 (02) :165-171
[2]  
CLIBY W, 1993, CANCER RES, V53, P2393
[3]   METASTATIC OVARIAN-CARCINOMA OF LARGE INTESTINAL ORIGIN SIMULATING PRIMARY OVARIAN-CARCINOMA - A CLINICOPATHOLOGICAL STUDY OF 25 CASES [J].
DAYA, D ;
NAZERALI, L ;
FRANK, GL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 97 (06) :751-758
[4]   Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers [J].
Dion, F ;
Mes-Masson, AM ;
Seymour, RJ ;
Provencher, D ;
Tonin, PN .
ONCOGENE, 2000, 19 (11) :1466-1472
[5]   Detecting colorectal cancer in stool with the use of multiple genetic targets [J].
Dong, SM ;
Traverso, G ;
Johnson, C ;
Geng, L ;
Favis, R ;
Boynton, K ;
Hibi, K ;
Goodman, SN ;
D'Allessio, M ;
Paty, P ;
Hamilton, SR ;
Sidransky, D ;
Barany, F ;
Levin, B ;
Shuber, A ;
Kinzler, KW ;
Vogelstein, B ;
Jen, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :858-865
[6]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[7]  
FELTMATE CM, 2005, METHOD MOL BIOL, P69
[8]   Masses simulating gynecologic diseases at CT and MR imaging [J].
Foshager, MC ;
Hood, LL ;
Walsh, JW .
RADIOGRAPHICS, 1996, 16 (05) :1085-1099
[9]   k-ras mutation may be an early event in mucinous ovarian tumorigenesis [J].
Garrett, AP ;
Lee, KR ;
Colitti, CR ;
Muto, MG ;
Berkowitz, RS ;
Mok, SC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (03) :244-251
[10]   Appendix cancer mimicking ovarian cancer [J].
Gehrig, PA ;
Boggess, JF ;
Ollila, DW ;
Groben, PA ;
Van Le, L .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) :768-772